Pictured: Jedd Wolchok
In the Clinic
By Media Staff  |  Thursday, March 8, 2012

Findings from a multidisciplinary research team led by Memorial Sloan Kettering medical oncologist and immunologist Jedd Wolchok could help shed light on the immune system’s role in fighting cancer.

Pictured: David Panicek & Barbara Raphael
Feature
By Jim Stallard, MA, Allyson Collins, MS, and Celia Gittelson, BA
Thursday, March 1, 2012

Memorial Sloan Kettering trains medical students, residents, and fellows to become leaders in cancer diagnosis and treatment.

Pictured: Martee Hensley
Prediction Tool
By Memorial Sloan Kettering  |  Thursday, March 1, 2012

Memorial Sloan Kettering investigators have developed a personalized tool to help women and their doctors predict overall survival at five years after a diagnosis of uterine leiomyosarcoma.

Pictured: Jatin Shah
Video
By Memorial Sloan Kettering  |  Tuesday, February 28, 2012

Many cancers that develop in the mouth, nose, throat, and larynx can be cured. Watch this series to learn how our experts collaborate to give patients the best chance of a positive outcome.

Pictured: Ann Zauber
In the Clinic
By Esther Napolitano, BS and Julie Grisham, MS
Thursday, February 23, 2012

For the first time, a new study has shown that removing polyps by colonoscopy not only prevents colorectal cancer from developing, but also prevents deaths from the disease.

Patient Story
By Memorial Sloan Kettering  |  Monday, February 20, 2012

When five-year-old CJ Postighone was diagnosed with a rare pediatric cancer called rhabdomyosarcoma, he came to Memorial Sloan Kettering to receive a combination of surgery, chemotherapy, and radiation therapy.

Pictured: Timothy Chan
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, February 15, 2012

Two Memorial Sloan Kettering studies provide new clues about genetic mutations that affect cell behavior and play a role in several types of cancer.

Pictured: Mark Bilsky
Q&A
By Memorial Sloan Kettering  |  Wednesday, February 15, 2012

The director of the Spine Tumor Center explains how this new, high-powered approach to radiation therapy has changed the way spine tumors are treated at Memorial Sloan Kettering.

Pictured: Halina Frydman
Patient Story
By Memorial Sloan Kettering  |  Monday, February 13, 2012

Soon after Halina Frydman’s husband noticed changes in his wife's personality, Halina was diagnosed with primary central nervous system lymphoma. She came to Memorial Sloan Kettering to receive treatment through a clinical trial.

Pictured: Ion Channel K2P1
Q&A
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, February 9, 2012

Structural biologist Stephen Long talks about how his team used x-ray crystallography to discover the structure of an ion channel called K2P1.

Pictured: Robert Motzer
In the Clinic
By Esther Napolitano, BS, Science Writer/Editor  |  Tuesday, February 7, 2012

The recent FDA approval of axitinib provides a viable treatment option for patients who progress on or cannot tolerate the side effects of other approved drugs for the disease.

Pictured: Memorial Sloan Kettering logo
In the News
By Julie Grisham, MS, Science Writer/Editor  |  Monday, February 6, 2012

Two of the year’s top five cancer research advances cited by the American Society of Clinical Oncology were led by Memorial Sloan Kettering investigators.

Pictured: Charles Sawyers & Howard Scher
In the News
By Media Staff  |  Friday, February 3, 2012

The success of an experimental prostate cancer treatment is an example of how academic research centers are playing a larger role in drug development, the Wall Street Journal reports.

Pictured: Marc Ladanyi & Laetitia Borsu
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Wednesday, February 1, 2012

Memorial Sloan Kettering researchers have performed the first large-scale genetic analysis of several pediatric cancers, identifying mutations and potential targets for therapies to treat the cancers.

Pictured: Monica Morrow
Perspective
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, January 31, 2012

Breast Surgical Service Chief Monica Morrow provides perspective on assessing the quality of surgical breast cancer treatment in an editorial in the February 1 issue of the Journal of the American Medical Association.

Center News

Stay Informed

Get the latest information about cancer care and research every month.